Tremfya expiration date?

When does Tremfya's main patent expire?
The primary patent protecting Tremfya (guselkumab) is set to expire in 2034 [1].

What happens after Tremfya's patent expiration?
Following patent expiration, the market may open to generic or biosimilar versions of Tremfya. This typically increases competition and can lead to lower prices for the medication [2].

Are there other forms of exclusivity for Tremfya?
Besides patent protection, drugs can have other forms of market exclusivity, such as data exclusivity or orphan drug exclusivity, which can extend the period before generics or biosimilars can enter the market [3]. Details on Tremfya's specific exclusivities beyond its main patent can be found on DrugPatentWatch.com [4].

Can biosimilars be approved before patent expiration?
In some cases, biosimilar manufacturers can seek FDA approval for their products before the relevant patents expire. However, they cannot launch their biosimilar until the patents and other exclusivities have lapsed, unless a court rules the patents invalid or not infringed [5].

What are the key patents for Tremfya?
The main patent for Tremfya covers its composition of matter, which is typically the strongest form of protection. Other patents might cover its manufacturing process, methods of use, or specific formulations [1][4]. Information on all patents associated with Tremfya is available through resources like DrugPatentWatch.com [4].

Who manufactures Tremfya?
Tremfya is manufactured by Janssen Biotech, Inc., a subsidiary of Johnson & Johnson [6].

What conditions does Tremfya treat?
Tremfya is approved to treat moderate to severe plaque psoriasis in adults and active psoriatic arthritis in adults [7].

What are the potential risks of Tremfya?
Tremfya can cause serious side effects, including an increased risk of infections. Patients should discuss any concerns about infections or other potential risks with their healthcare provider [7].

Sources:
[1] DrugPatentWatch.com
[2] DrugPatentWatch.com
[3] DrugPatentWatch.com
[4] DrugPatentWatch.com
[5] DrugPatentWatch.com
[6] U.S. Food & Drug Administration (FDA)
[7] Tremfya Prescribing Information